The Journal of Allergy and Clinical Immunology
Volume 125, Issue 2 , Pages 357-358, February 2010

Long-acting β-agonists and inhaled corticosteroids: Is the whole greater than the sum of its parts?

  • Shamsah Kazani, MD
    • ,
  • Elliot Israel, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Elliot Israel, MD, Brigham and Women's Hospital, Pulmonary and Critical Care Division, 75 Francis St, Boston, MA 02115.

Pulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass

Received 3 December 2009; accepted 7 December 2009.

Key words: Asthma, inhaled corticosteroids, long-acting beta-agonists, synergism

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Disclosure of potential conflict of interest: E. Israel has consultant arrangements with Abbott, Amgen, Astellas Pharma US, Cowen and Co, GlaxoSmithKline, Icagen, MedImmune, Merck, NKT Therapeutics, Novartis, PDL BioPharma, Schering-Plough, Sepracor, and Teva Specialty Pharmaceuticals and receives research support from Aerovance, Ception Therapeutics, Genentech, Icagen, Johnson & Johnson, MedImmune, the National Institutes of Health, and Novartis. S. Kazani has declared no conflict of interest.

PII: S0091-6749(09)01818-1

doi:10.1016/j.jaci.2009.12.021

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 2 , Pages 357-358, February 2010

Article Tools